{"id":"https://openalex.org/W2283567452","doi":null,"title":"The synthesis and radiolabeling of 2-nitroimidazole derivatives of cyclam and their preclinical evaluation as positive markers of tumor hypoxia.","display_name":"The synthesis and radiolabeling of 2-nitroimidazole derivatives of cyclam and their preclinical evaluation as positive markers of tumor hypoxia.","alternate_titles":[],"publication_year":2002,"publication_date":"2002-06-01","ids":{"openalex":"https://openalex.org/W2283567452","mag":"2283567452","pmid":"https://pubmed.ncbi.nlm.nih.gov/12050331"},"language":"en","primary_location":{"id":"pmid:12050331","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12050331","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2283567452"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108399225","display_name":"Edward L. Engelhardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward L Engelhardt","raw_affiliation_strings":["Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110388064","display_name":"Richard F. Schneider","orcid":"https://orcid.org/0000-0003-0947-4977","observed_orcids":["https://orcid.org/0000-0003-0947-4977"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard F Schneider","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062942186","display_name":"Steven H. Seeholzer","orcid":"https://orcid.org/0000-0001-5243-7667","observed_orcids":["https://orcid.org/0000-0001-5243-7667"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven H Seeholzer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108371105","display_name":"Corinne C. Stobbe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Corinne C Stobbe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110119604","display_name":"J. Donald Chapman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Donald Chapman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7335,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.6972242,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"43","issue":"6","first_page":"837","last_page":"850"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclam","display_name":"cyclam","score":0.4519999921321869},{"id":"https://openalex.org/keywords/tumor-hypoxia-imaging","display_name":"tumor hypoxia imaging","score":0.8949999809265137},{"id":"https://openalex.org/keywords/radiolabeled-imaging-agents","display_name":"radiolabeled imaging agents","score":0.5730000138282776},{"id":"https://openalex.org/keywords/copper-64","display_name":"copper-64","score":0.8640000224113464},{"id":"https://openalex.org/keywords/technetium-99m","display_name":"technetium-99m","score":0.9330000281333923},{"id":"https://openalex.org/keywords/copper-67","display_name":"copper-67","score":0.9139999747276306},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.7089999914169312},{"id":"https://openalex.org/keywords/emt6-tumor","display_name":"EMT6 tumor","score":0.753000020980835},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.6050000190734863},{"id":"https://openalex.org/keywords/tumor-to-blood-ratio","display_name":"tumor-to-blood ratio","score":0.6629999876022339},{"id":"https://openalex.org/keywords/radiopharmaceutical-synthesis","display_name":"radiopharmaceutical synthesis","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2776384444","wikidata":"https://www.wikidata.org/wiki/Q1970333","display_name":"Cyclam","level":3,"score":0.752519428730011},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7504850625991821},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.7375146150588989},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6982922554016113},{"id":"https://openalex.org/C2779081379","wikidata":"https://www.wikidata.org/wiki/Q7852677","display_name":"Tumor hypoxia","level":3,"score":0.6060513257980347},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.5508397817611694},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.515182614326477},{"id":"https://openalex.org/C2776313096","wikidata":"https://www.wikidata.org/wiki/Q3529346","display_name":"Tirapazamine","level":4,"score":0.4737221300601959},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.35456883907318115},{"id":"https://openalex.org/C177322064","wikidata":"https://www.wikidata.org/wiki/Q750955","display_name":"Radiochemistry","level":1,"score":0.3502345085144043},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2655814588069916},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22347286343574524},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.1472557783126831},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.13086062669754028},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12871453166007996},{"id":"https://openalex.org/C544153396","wikidata":"https://www.wikidata.org/wiki/Q11426","display_name":"Metal","level":2,"score":0.0},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007553","descriptor_name":"Isotope Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009593","descriptor_name":"Nitroimidazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011916","descriptor_name":"Rats, Inbred F344","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015687","descriptor_name":"Cell Hypoxia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:12050331","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12050331","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Journal Article"},{"id":"mag:2283567452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12050331","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.530.5267","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.530.5267","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnm.snmjournals.org/content/43/6/837.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1613980371","display_name":"Radionuclide Resource for Cancer Applications","funder_award_id":"R24CA086307","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5343904992","display_name":"NUCLEAR MEDICINE MARKERS OF TUMOR OXYGENATION","funder_award_id":"R01CA055893","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000285491","display_name":"Comprehensive Cancer Center Program at Fox Chase","funder_award_id":"P30CA006927","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W951668","https://openalex.org/W19456855","https://openalex.org/W56929591","https://openalex.org/W1259399738","https://openalex.org/W1484585927","https://openalex.org/W1490479332","https://openalex.org/W1523500414","https://openalex.org/W1619631706","https://openalex.org/W1848872330","https://openalex.org/W1966709363","https://openalex.org/W1972145544","https://openalex.org/W1978370833","https://openalex.org/W1994216439","https://openalex.org/W1997112823","https://openalex.org/W2006654035","https://openalex.org/W2009821059","https://openalex.org/W2011636435","https://openalex.org/W2014822355","https://openalex.org/W2015859554","https://openalex.org/W2017025137","https://openalex.org/W2025275406","https://openalex.org/W2036422260","https://openalex.org/W2036622441","https://openalex.org/W2054695479","https://openalex.org/W2060354459","https://openalex.org/W2062109032","https://openalex.org/W2064248272","https://openalex.org/W2075473734","https://openalex.org/W2083336230","https://openalex.org/W2084654037","https://openalex.org/W2091774457","https://openalex.org/W2093988815","https://openalex.org/W2110155388","https://openalex.org/W2117620147","https://openalex.org/W2137061905","https://openalex.org/W2139338030","https://openalex.org/W2157259121","https://openalex.org/W2157607856","https://openalex.org/W2262919211","https://openalex.org/W2418648350","https://openalex.org/W2951722029"],"related_works":["https://openalex.org/W2051439432","https://openalex.org/W2001007240","https://openalex.org/W2117620147","https://openalex.org/W1980835388","https://openalex.org/W2172893418","https://openalex.org/W1977848542","https://openalex.org/W1001320078","https://openalex.org/W2038010912","https://openalex.org/W2325363487","https://openalex.org/W2005111116"],"abstract_inverted_index":{"UNLABELLED:":[0],"The":[1,42,114,144,204,240,265,309],"cyclam":[2],"ligand":[3],"(1,4,8,11-tetraazacyclotetradecane)":[4],"was":[5,21,60,112,141,253,289,300],"condensed":[6],"with":[7,46,127,196,220,226,380,383],"various":[8],"azomycin-containing":[9],"synthons":[10],"to":[11,31,55,85,89,106,247,258,357,363,376],"produce":[12],"chemical":[13],"compounds":[14],"that":[15,23,103,243,259,304,350],"could":[16,373],"chelate":[17],"radioactive":[18],"metals.":[19],"It":[20],"expected":[22],"these":[24,200,208],"radiolabeled":[25,45],"markers":[26,43,124,167,198,210,381],"would":[27],"become":[28],"bound":[29],"selectively":[30],"hypoxic":[32,87,138],"cells":[33,57,359],"on":[34],"the":[35,73,76,79,94,99,109,122,159,165,250,261,277,338,343],"bioreduction":[36],"of":[37,65,78,82,96,108,121,164,175,207,249,260,267,314,334,342,366],"their":[38,245],"azomycin":[39,336],"substituent.":[40],"METHODS:":[41],"were":[44,125,168,194],"(99m)Tc,":[47],"(67)Cu,":[48,386],"or":[49,237],"(64)Cu.":[50],"Their":[51],"uptake":[52,206],"and":[53,67,118,155,158,161,180,229,275,279,293,307,311,316,331,362,371,385],"binding":[54,84,105,246],"tumor":[56,156,205,299,358,378],"in":[58,115,153,187,270,273,276,283,298,305,319,360],"vitro":[59,361],"characterized":[61],"as":[62],"a":[63],"function":[64],"time":[66],"oxygen":[68,97,241,263],"concentration.":[69],"These":[70,347],"data":[71,348],"defined":[72],"hypoxia-specific":[74,234],"factor,":[75],"ratio":[77],"initial":[80],"rate":[81,111,252],"marker":[83,341],"severely":[86],"relative":[88],"aerobic":[90],"cells.":[91],"In":[92],"addition,":[93],"concentration":[95,242],"(in":[98],"equilibrium":[100],"gas":[101],"phase)":[102],"inhibited":[104,244],"50%":[107,248],"maximum":[110],"determined.":[113],"vivo":[116],"biodistribution":[117],"clearance":[119],"kinetics":[120],"favorable":[123],"investigated":[126],"severe":[128],"combined":[129],"immune":[130],"deficiency":[131],"mice":[132,274],"bearing":[133],"EMT-6":[134,271],"tumors":[135,272,282,365],"whose":[136],"radiobiologic":[137,262],"fraction":[139],"(RHF)":[140],"approximately":[142,212,254,290],"40%.":[143],"specific":[145],"activity":[146,297,318],"(percentage":[147],"injected":[148],"dose":[149],"per":[150],"gram":[151],"[%ID/g])":[152],"normal":[154],"tissue":[157],"tumor-to-blood":[160,310],"tumor-to-muscle":[162,312],"ratios":[163,313],"optimal":[166,339],"also":[169],"measured":[170],"for":[171,328],"Dunning":[172],"prostate":[173,281],"carcinomas":[174],"anaplastic":[176,278],"(RHF":[177,182],"=":[178,238],"15%-20%)":[179],"well-differentiated":[181,280],"<":[183],"1%)":[184],"histology":[185],"growing":[186],"Fischer":[188],"X":[189],"Copenhagen":[190],"rats.":[191,202],"Planar":[192],"images":[193],"acquired":[195],"some":[197,351],"from":[199],"tumor-bearing":[201,321],"RESULTS:":[203],"cyclam-based":[209],"is":[211],"10":[213],"times":[214],"higher":[215,324],"when":[216,224],"they":[217],"are":[218,323],"labeled":[219,225,382],"copper":[221],"isotopes":[222],"than":[223,303,325],"(99m)Tc.":[227],"FC-327":[228],"FC-334,":[230],"di-azomycin-substituted":[231],"cyclams,":[232],"exhibited":[233],"factors":[235],">":[236],"7.0.":[239],"maximal":[251],"0.5%":[255],"O(2),":[256],"similar":[257],"effect.":[264],"%ID/g":[266],"(64)Cu-FC-334":[268,317],"retained":[269],"rats":[284,322],"6":[285],"h":[286],"after":[287],"administration":[288],"6.5,":[291],"0.4,":[292],"0.1,":[294],"respectively.":[295,387],"Marker":[296],"always":[301],"less":[302],"liver":[306],"kidney.":[308],"(64)Cu-FC-327":[315],"R3327-AT":[320],"those":[326,333],"observed":[327],"(64)Cu-di-acetyl-bis":[329],"(N(4)-methylthiosemicarbazone)":[330],"approach":[332],"beta-D-(125)I-iodinated":[335],"galactopyranoside,":[337],"hypoxia":[340,379],"azomycin-nucleoside":[344],"class.":[345],"CONCLUSION:":[346],"suggest":[349],"azomycin-cyclams":[352],"exhibit":[353],"good":[354],"hypoxia-marking":[355],"potential":[356],"animal":[364],"known":[367],"RHF.":[368],"Both":[369],"PET":[370],"SPECT":[372],"be":[374],"used":[375],"image":[377],"(64)Cu":[384]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2283567452","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
